Astria Therapeutics (ATXS) Q4 2022 Earnings

22MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1.18
-1.02
-0.87
-0.71

Details

Expected EPS
-0.71
Actual EPS
-0.72
Surprise EPS
-0.01
Surprise Percent
+1.41%

Description

Astria Therapeutics (ATXS) has reported earnings of -0.72 per share for Q4 2022.

0 Comments

Share your thoughts